Accelerating biohybrid research while ensuring safe and beneficial outcomes involves managing the tension between scientific freedom and social responsibility. Permissionless innovation, characterized by limited oversight and rapid experimentation, maximizes scientific freedom while downgrading consideration for future risks. In contrast, responsible innovation calls for ongoing stakeholder engagement, reflection, risk anticipation, social evaluation, and commitment to responsive design practices. While seemingly rooted in opposing ideologies – one reflecting risk tolerance, the other risk aversion – these methodologies share many similarities and can be integrated to afford scientific freedom during early-stage work while, as a project matures, providing strategies for ensuring and safeguarding societal benefit. By incorporating graduated oversight, the biohybrid research community has an opportunity to accelerate development and preserve safety, allowing investigators to capitalize on developing government interest.